Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Bilia AB publ
Mandate

Vinge has advised Bilia AB publ

December 05, 2016 Automotive, Mobility and Electrification

Vinge has advised Bilia AB (publ), listed on NASDAQ Stockholm, in conjunction with a tap issue of MSEK 250 within the scope of its non-subordinated corporate bonds, with a maturity date in March 2021.

The issue was performed as an interest expense corresponding to STIBOR 3 months + 150 interest points up to maturity. In total, the new outstanding amount following the issue is MSEK 750.

Vinge’s team consisted of responsible advokat Yohanna Öhrnegård assisted by Lina André.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of SEK 350 million before transaction costs.
April 22, 2026

Vinge has advised Alder on the establishment of Alder Strategic Opportunities Fund I and on a fund credit facility agreement in connection with the fundraising

 Vinge has advised Alder on the establishment of the continuation fund Alder Strategic Opportunities Fund I AB. In connection with the establishment, the fund acquires the portfolio companies SI and SMG from Alder II. Vinge also advised Alder on the entering into of a fund credit facility agreement with SEB.
April 20, 2026

Vinge has advised IK Partners in connection with the acquisition of Selatek

 Vinge has advised IK Partners (“IK”) in connection with IK X Fund’s acquisition of SELATEK Holding AB (“Selatek”), a leading Swedish technical installation platform, from Amplio Private Equity AB and the minority shareholders.
April 20, 2026